BUY Mankind Pharma Limited — Dhvani Patel
byDhvani PatelHorizon: Intraday11 Jun 2026, 12:40 pm ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·3 Jun · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Mankind Pharma
- BUY — Rajesh Satpute7 Oct 2026 · Next day · target ₹2,550 · SL hit
- BUY — Swati Hotkar, Nirmal Bang Securities7 Oct 2026 · Same day · target ₹2,580 · Expired
- SELL — Macquarie7 Oct 2026 · ~1 year · target ₹2,200 · Target hit
- BUY — Vishvesh Chauhan, ChaseAlpha30 Sept 2026 · ~2 weeks · target ₹2,640 · SL hit
- BUY — Raja Venkatraman30 Sept 2026 · ~3 months · target ₹2,800 · SL hit
More from Dhvani Patel
- BUY The Phoenix Mills15 Oct 2026 · ~2 weeks · target ₹2,100 · Active
- BUY Manappuram Finance15 Oct 2026 · ~2 weeks · target ₹370 · SL hit
- BUY Cholamandalam Investment and Finance Company9 Oct 2026 · ~2 weeks · target ₹1,660 · SL hit
- SELL United Spirits8 Oct 2026 · ~2 weeks · target ₹1,280 · SL hit
- SELL PB Fintech8 Oct 2026 · ~2 weeks · target ₹950 · SL hit

